Category Archives: Pr Newswire

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication

CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals in the U.S. died from drug overdose deaths involving cocaine in 2022; there is currently no FDA-approved product for cocaine intoxication Topline results are expected in the first half of 2025 CHATHAM, N.J., Aug. 20, […]

Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer

Appointment adds biotech veteran with over two decades of business development, strategy, and operational experience to Cidara’s management team SAN DIEGO, Aug. 19, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of […]

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease transmission 50,000 doses of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) will be donated to Direct Relief for potential deployment across often difficult-to-reach locations, and as informed by local and regional health authorities GAITHERSBURG, Md., Aug. 19, […]

Latest Version of the Appian Platform Transforms Enterprise Data and Process Automation with AI-Driven Innovations

SYDNEY, Aug. 19, 2024 /PRNewswire/ — Appian (Nasdaq: APPN) today announced the latest version of the Appian Platform, designed to transform how organisations orchestrate enterprise data and automate processes. This release delivers support for more enterprise AI use cases with expanded compliance, offering a strong framework to help organisations prepare for current and forthcoming AI regulations. […]

Hbada Creates Professional Ergonomic Chairs, Hbada E3 Ergonomic Office Chair Offers Comfortable Options for Prolonged Sitting

FONTANA, Calif., Aug. 20, 2024 /PRNewswire/ — As the times evolve, the duration of sedentary lifestyles among the general public continues to increase, leading to a rapid growth in lumbar and shoulder disc diseases. Consequently, the demand for ergonomic chairs has soared. With remarkable insight, Hbada has embraced the trends of the era, continuously crafting innovative […]

James Hardie Releases Annual Sustainability Report and Builds a Culture of Sustainability

Company announces progress in business integration, product resiliency and community impact   SYDNEY & CHICAGO, Aug. 20, 2024 /PRNewswire/ — James Hardie Industries plc (ASX: JHX; NYSE: JHX), (“James Hardie” or the “Company”), the North American leader in fiber cement exterior design solutions and a company inspiring how communities design, build and grow, today released […]

Forever New Transforms Store Order Fulfillment with OneView

SaaS unified commerce platform positions the retailer to respond to customer preferences, increase store efficiency and drive brand loyalty. BOSTON, Aug. 20, 2024 /PRNewswire/ — OneView Commerce, the leader in unified commerce SaaS store solutions for omnichannel retailers, today announced that the global women’s fashion brand Forever New is leveraging the OneView Unified Commerce platform to implement […]

Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence

DALLAS, Aug. 19, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Dr. Jeffrey Carter will present data from an ongoing prospective multicenter study analyzing the use of […]

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

FLORHAM PARK, N.J., Aug. 19, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today the pricing of its underwritten offering of 8,695,652 shares of its common stock and pre-funded warrants to purchase 2,608,922 shares of common stock. The shares of […]